Listed

Resmed Inc

RMDNYSECIK 943819HealthcareFiscal year ends Jun 30

Latest reported revenue, Q4 FY2026$1.46bnRevenue, Q4 FY2026, three months to 2026-06-30$1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2026, from the 10-K filed Aug 13, 2026.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.46bnRevenue, Q4 FY2026, three months to 2026-06-30$1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure+8.6% on a year earlier
  • Gross margin58.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $861.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure−2.0 pts on a year earlier
  • Operating margin30.7%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $448.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure−3.1 pts on a year earlier
  • Net margin26.2%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $383.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure−2.0 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow$403.5mFree cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $454.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Capital expenditure: $51.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure−20.6% on a year earlier

Last eight quarters

Full statements
Revenue$1.46bnGross margin 58.8%
Diluted EPS$2.74, Q3 FY2026
Free cash flow$403.5m, Q4 FY2026
Resmed Inc, key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$m1,225Revenue, Q1 FY2025, three months to 2024-09-30$1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure1,282Revenue, Q2 FY2025, three months to 2024-12-31$1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure1,292Revenue, Q3 FY2025, three months to 2025-03-31$1.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure1,348Revenue, Q4 FY2025, three months to 2025-06-30$1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure1,336Revenue, Q1 FY2026, three months to 2025-09-30$1.34bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure1,423Revenue, Q2 FY2026, three months to 2025-12-31$1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure1,431Revenue, Q3 FY2026, three months to 2026-03-31$1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure1,464Revenue, Q4 FY2026, three months to 2026-06-30$1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure
Gross margin%58.6%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $717.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure58.6%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $751.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure59.3%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $766.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure60.8%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $820.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure61.5%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $820.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Revenue: $1.34bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure61.8%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $878.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure62.2%Gross margin, Q3 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $891.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure58.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $861.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure
Operating margin%31.6%Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $387.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure32.5%Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $417.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure33.0%Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $426.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure33.7%Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $454.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure33.4%Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $446.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Revenue: $1.34bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure34.6%Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $491.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure34.9%Operating margin, Q3 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $499.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure30.7%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $448.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure
Net margin%25.4%Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: $311.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure26.9%Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: $344.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure28.3%Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: $365.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure28.2%Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: $379.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure26.1%Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: $348.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.34bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure27.6%Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: $392.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure27.9%Net margin, Q3 FY2026, three months to 2026-03-31. net income / revenueNet income: $398.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Revenue: $1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figure26.2%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $383.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share2.11Diluted EPS, Q1 FY2025, three months to 2024-09-30$2.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure2.34Diluted EPS, Q2 FY2025, three months to 2024-12-31$2.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure2.48Diluted EPS, Q3 FY2025, three months to 2025-03-31$2.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figurenot reported (Diluted EPS not reported)2.37Diluted EPS, Q1 FY2026, three months to 2025-09-30$2.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure2.68Diluted EPS, Q2 FY2026, three months to 2025-12-31$2.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-30, accession 0000943819-26-000007.Report this figure2.74Diluted EPS, Q3 FY2026, three months to 2026-03-31$2.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000943819-26-000025.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$m308Free cash flow, Q1 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $325.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Capital expenditure: $17.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure288Free cash flow, Q2 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $308.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-30, accession 0000943819-26-000007. Derived: 6-month figure less the 3-month figure.Capital expenditure: $20.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-30, accession 0000943819-26-000007. Derived: 6-month figure less the 3-month figure.Report this figure558Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $578.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000943819-26-000025. Derived: 9-month figure less the 6-month figure.Capital expenditure: $20.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000943819-26-000025. Derived: 9-month figure less the 6-month figure.Report this figure508Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $538.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Capital expenditure: $30.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure414Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $457.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Capital expenditure: $43.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0000943819-25-000090.Report this figure311Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $339.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-30, accession 0000943819-26-000007. Derived: 6-month figure less the 3-month figure.Capital expenditure: $28.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-30, accession 0000943819-26-000007. Derived: 6-month figure less the 3-month figure.Report this figure520Free cash flow, Q3 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $554.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000943819-26-000025. Derived: 9-month figure less the 6-month figure.Capital expenditure: $33.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000943819-26-000025. Derived: 9-month figure less the 6-month figure.Report this figure404Free cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $454.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Capital expenditure: $51.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$5.65bnGross margin 61.1%
Diluted EPS$10.43, FY2026
Free cash flow$1.65bn, FY2026
Resmed Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m3,578Revenue, FY2022, twelve months to 2022-06-30$3.58bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure4,223Revenue, FY2023, twelve months to 2023-06-30$4.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure4,685Revenue, FY2024, twelve months to 2024-06-30$4.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure5,146Revenue, FY2025, twelve months to 2025-06-30$5.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure5,653Revenue, FY2026, twelve months to 2026-06-30$5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure
Gross margin%56.6%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: $2.02bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-08-09, accession 0000943819-24-000013.Revenue: $3.58bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure55.8%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $2.36bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-08, accession 0000943819-25-000035.Revenue: $4.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure56.7%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $2.66bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $4.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure59.4%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $3.05bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure61.1%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $3.45bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure
Operating margin%28.0%Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: $1.00bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-08-09, accession 0000943819-24-000013.Revenue: $3.58bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure26.8%Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: $1.13bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-08, accession 0000943819-25-000035.Revenue: $4.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure28.2%Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: $1.32bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $4.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure32.7%Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: $1.69bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure33.4%Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: $1.89bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure
Net margin%21.8%Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: $779.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-08-09, accession 0000943819-24-000013.Revenue: $3.58bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure21.3%Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: $897.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-08, accession 0000943819-25-000035.Revenue: $4.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure21.8%Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: $1.02bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $4.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure27.2%Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: $1.40bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure26.9%Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: $1.52bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-13, accession 0000943819-26-000047.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure
Diluted EPS$ per share5.30Diluted EPS, FY2022, twelve months to 2022-06-30$5.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure6.09Diluted EPS, FY2023, twelve months to 2023-06-30$6.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure6.92Diluted EPS, FY2024, twelve months to 2024-06-30$6.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure9.51Diluted EPS, FY2025, twelve months to 2025-06-30$9.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure10.43Diluted EPS, FY2026, twelve months to 2026-06-30$10.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure
Free cash flow$m216Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: $351.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-08-09, accession 0000943819-24-000013.Capital expenditure: $134.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-08-09, accession 0000943819-24-000013.Report this figure574Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: $693.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-08, accession 0000943819-25-000035.Capital expenditure: $119.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-08-08, accession 0000943819-25-000035.Report this figure1,302Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $1.40bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047.Capital expenditure: $99.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure1,662Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.75bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047.Capital expenditure: $89.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure1,650Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.81bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-13, accession 0000943819-26-000047.Capital expenditure: $156.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-13, accession 0000943819-26-000047.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $102.0k
Resmed Inc, open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-23Rider Michael JGlobal General Counsel, Officer Sale400$255.00$102.0kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Resmed Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$2.40bn12,317,194Added+223,171
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.85bn9,474,129Added+7,713
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$1.54bn7,913,661Added+49,739
STATE STREET CORP2026-06-30$1.30bn6,680,735Added+37,567
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$845.2m4,352,320Reduced−553
Bank of New York Mellon Corp2026-06-30$818.0m4,197,610Reduced−727,776
FIRST TRUST ADVISORS LP2026-06-30$444.1m2,278,696Added+740,871
Invesco Ltd.2026-06-30$402.1m2,063,578Added+106,964
MORGAN STANLEY2026-06-30$375.9m1,928,931Reduced−757,890
NORTHERN TRUST CORP2026-06-30$330.6m1,696,674Reduced−29,019

Recent filings

All 1,915 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Resmed Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2916:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-437783
2026-10-0116:34 ETDEF 14AProxy statementPeriod 2026-06-300000943819-26-000080
2026-09-0116:30 ET8-K8.01 Other events0001193125-26-378487
2026-08-1716:30 ET8-K4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-354154
2026-08-1317:17 ET10-KAnnual reportPeriod 2026-06-300000943819-26-000047
2026-08-0616:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-337962
2026-07-0717:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-297658
2026-05-0118:19 ET10-QQuarterly reportPeriod 2026-03-310000943819-26-000025
2026-04-3016:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-197282
2026-04-3016:06 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-197192

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Aug 13, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q1 FY2027, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
943819
Tickers
RMD, RSMDF
Exchange
NYSE
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Jun 30
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.